PR Newswire BiotechOriginal article
Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma
Phase 2Positive
AI Analysis
Summary
Alpheus Medical has initiated a Phase 2b trial of an investigational non-invasive, drug-centered therapy for newly diagnosed glioblastoma, with 10 patients enrolled to date.
Clinical Trial Data
Phase
2b
Patients
10
Importance:5/10
Sentiment:
0.40
glioblastomaphase_2btrial_initiationoncologybrain_cancer
Related Companies
Read the original article
Published by PR Newswire Biotech on April 9, 2026 1:03 PM